The prion protein (PrP C ) is predominantly expressed in the nervous and immune systems and is involved in relevant cell signaling. Microglia participate in neuroimmune interactions, and their regulatory mechanisms are critical for both health and disease. Despite recent reports with a microglial cell line, little is known about the relevance of PrP C in brain microglia. We investigated the role of PrP C in mouse primary microglia, and found no differences between wild type and Prnp-null cells in cell morphology or the expression of a microglial marker. Translocation of NF-κB to the nucleus also did not differ, nor did cytokine production. The levels of iNOS were also similar and, finally, microglia of either genotype showed no differences in either rates of phagocytosis or migration, even following activation. Thus, functional roles of PrP C in primary microglial cells are -if presentmuch more subtle than in transformed microglial cell lines.
Introduction
The prion protein (PrP C ) is a highly conserved glycosylphosphatidylinositol (GPI)-anchored glycoprotein, located at the surface of the plasma membrane and expressed mainly in the nervous and immune system (Stahl et al., 1987; Prusiner, 1998) . Despite a known association with neurodegenerative diseases, its physiological functions are still controversial, although it is believed that PrP C acts as a scaffold for the assembly of multi-component signaling complexes at the cell surface (Aguzzi et al., 2008; Linden et al., 2008) . Among the immune cells, PrP C has been implicated in the physiology of lymphocytes, macrophages, dendritic cells, neutrophils and others (Isaacs et al., 2006; Mariante et al., 2012) , and a role of PrP C was reported in the activation of microglia (Brown et al., 1998) . The latter are mononuclear phagocytes resident in the brain parenchyma, and constitute about 5 to 20% of the total number of glial cells, depending on the specific region of the brain (Lawson et al., 1990; Perry and Gordon, 1991) . They constitute the main representative of the immune system in the central nervous system, and participate in both neuronal homeostasis and in inflammation (Saijo and Glass, 2011) .
Microglia are activated in the context of numerous injuries or diseases that affect the CNS, both in human and in corresponding animal models (Perry et al., 2010) . However, the functions of these cells in neurodegenerative diseases are not entirely understood. Microglia can have either a protective role, by removing protein aggregates in transmissible spongiform encephalopathies (Brown and Kretzschmar, 1997; Rezaie and Lantos, 2001) and Aβ aggregates in Alzheimer disease (Lee and Landreth, 2010; Sokolowski and Mandell, 2011) , or a pathogenic role, through exacerbation of inflammation with the production of cytokines, inflammatory mediators and other neurotoxins that may contribute to neuronal dysfunction and damage (Perry et al., 2010; Saijo and Glass, 2011) . Thus, it is expected that the activation of microglia is tightly regulated, and investigation of its control mechanisms should contribute to better understanding of both the modulation of its phenotypes and its roles in pathophysiology.
Microglial PrP C has received little attention following the early evidence for its role in cellular activation (Brown et al., 1998) , and only recently a series of studies of the microglial cell line BV-2 revived this issue. Thus, an increase in the transcription of the PrP C -coding Prnp gene was reported following stimuli such as treatment with the neurotoxic prion peptide PrP 106-126 (Bai et al., 2010) or infection with Mycobacterium bovis . Further, the silencing of PrP C with siRNA indicated that PrP C affects the response of BV-2 cells to bacterial infection and modulates the change of those cells' phenotype from a quiescent to an activated state .
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Nonetheless, despite the evidence for the involvement of PrP C in both the activation and cell responses of this microglial cell line, the relationship between PrP C and the physiology of microglia in vivo or ex vivo is unclear. Here, we examined the functional properties of primary cultures of microglia obtained from both wild type and Prnpnull mouse brains. The results showed no evidence of participation of PrP C in microglial activation and functions.
Materials and methods

Reagents
DMEM-F12 culture medium was from Gibco. Fetal bovine serum was from Cultilab. LPS (Salmonella enterica) and FITC-labeled zymosan (Saccharomyces cerevisiae) were from Sigma and Invitrogen, respectively. Monoclonal anti-NF-κB p65 (20/NF-κB/p65) and anti-PrP C (SAF83) antibodies were from BD Biosciences and Cayman Chemical, respectively. Polyclonal anti-Iba-1 and anti-iNOS were from Wako and Abcam, respectively, and anti-Erk2 was from Santa Cruz Biotechnology. Secondary antibodies for immunofluorescence (Alexa Fluor 488 and Alexa Fluor 555) and western blots (anti-mouse IgG-HRP) were from Life Technologies and Cell Signaling, respectively. ELISA kits for cytokine assays were from eBioscience.
Mouse strains and genotyping
Prion protein knockout mice originally produced in 129/Ola background (Manson et al., 1994) , and serially backcrossed into the C57BL/ 10SnJ strain (Tribouillard-Tanvier et al., 2009) , were kindly provided by Bruce Chesebro and Richard Race (Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, USA). Descendants of heterozygous littermates were maintained by serial backcrossing into C57BL/10SnJ, and used to derive wild type and Prnp-null mice, here referred to as B10.129Ola. Animals were housed in plastic boxes with food and water ad libitum, and were maintained in a 12 h light/dark cycle. Experiments were done with newborn mice (0 to 2 postnatal days) in accordance with current guidelines for the care and use of laboratory animals, as described by the National Institutes of Health and approved by the Committee for the Use of Experimental Animals from the Center of Health Sciences, Federal University of Rio de Janeiro.
All mice used in the present study were genotyped by PCR as described elsewhere (Steele et al., 2006) . Briefly, DNA from tails was amplified in a multiplex reaction using the primer pairs 5′-TCATCCCA CGATCAGGAAGATGAG-3′ and 5′-ATGGCGAACCTTGGCTACTGGCTG-3′, which anneal to the start and stop codons of the Prnp gene open reading frame and generate a fragment of 750 bp, and 5′-TTGAGCCTGGCGAACA GTTC-3′ and 5′-GATGGATTGCACGCAGGTTC-3′, which anneal to the neomycin resistance gene present in Prnp-null mice and generate a product of 550 bp. Cycling conditions were 94°C for 3 min, 30 cycles at 94°C for 30 s, 62°C for 30 s, and 72°C for 1 min, followed by a final extension at 72°C for 10 min. PrP C content from microglial cell lysates was further verified by western blots (Supplemental methods and Supplemental Fig. 1 ).
Primary cultures of microglial cells
Microglial cells were obtained from the brains of newborn mice as described previously (Théry et al., 1991; Fonseca et al., 2012) . Briefly, mice were decapitated, their brains were dissected and the meninges were carefully stripped off. Tissues were mechanically dissociated and resuspended in DMEM-F12 medium supplemented with L-glutamine, 1% penicillin/streptomycin, and 10% fetal bovine serum. Dissociated cells were plated in poly-L-ornithine-coated flasks and incubated at 37°C for 14 days in a humidified chamber with 5% CO 2 . Floating microglial cells were collected from culture supernatants, counted, plated as described in the following sections and either stimulated or not with 1 μg/ml LPS for 24-72 h. Four to six mice pups of each genotype were used for each culture. Microglial cultures presented N97% purity as verified by Iba-1 expression.
Immunocytochemistry
Microglial cells plated in a 24-well plate containing round coverslips (7 × 10 4 cells per well) were either treated or not with LPS for 24 h, fixed with 4% paraformaldehyde in phosphate buffer 0.1 M (pH 7.4), permeabilized with 0.5% Triton X-100 and blocked with 3% bovine serum albumin. The coverslips were incubated overnight at 4°C with primary antibodies anti-Iba-1 (1:200), anti-NF-κB (1:50) or anti-iNOS (1:300), followed by a secondary antibody (Alexa Fluor 488 or 555, 1:300) for 90 min at room temperature. Cell nuclei were stained with DAPI (1 μg/ml). The coverslips were mounted and observed in Zeiss Axio Imager.M2 fluorescence microscope equipped with an ApoTome module. The number of iNOS-positive cells was calculated from images acquired with the AxioVision mosaic tool, which generated images consisting of 225 photos (15 × 15 matrix) covering virtually the entire area of each coverslip. At least 12,000 cells of each group were counted and analyzed in each experiment. The fluorescence intensity of iNOS staining was estimated as described elsewhere (Gavet and Pines, 2010) and normalized to the fluorescence of WT untreated microglial cells. We measured the individual fluorescence of at least 300 cells of each group. Image analysis, processing and quantification were done with AxioVision 4.8, Adobe Photoshop CS5 and ImageJ 1.48v softwares.
Cytokine measurements
The release of cytokines was estimated from cells seeded in 24-well plates (5 × 10 5 cells per well), and either treated or not with LPS for 24 h as described above. Supernatants were collected, centrifuged at 10,000 g for 5 min, and the levels of IL-1β, IL-6, TNF-α, IL-10 and IL-4 were measured by ELISA according to the manufacturer's instructions.
Phagocytosis assay
Microglial cells were plated (7 × 10 4 cells per well) and either treated or not with LPS as described above. Zymosan-FITC bioparticles were opsonized with 30% normal mouse serum in DMEM-F12 for 1 h at 37°C, and added to cell cultures 90 min prior to the end of LPS treatment at a ratio of 10:1 (zymosan:microglial cell). Afterwards, cells were washed three times with cold phosphate buffered saline to remove non-phagocytized particles, fixed with 4% paraformaldehyde and labeled with anti-Iba-1 (1:200) and DAPI as described before. The slides were examined and photographed in a Zeiss Axio Imager.M2 fluorescence microscope. For quantification, cells containing three or more internalized zymosan particles were scored as phagocytic (de Almeida et al., 2005) . The number of phagocytic cells was calculated from 100 photos (10 × 10 matrix) of each coverslip. At least 12,000 cells of each group were counted and analyzed.
Scratch wound migration assay
Microglial cells (7 × 10 4 cells per well) were seeded in 96-well plates and incubated overnight in a humidified chamber at 37°C with 5% CO 2 . Twenty-four hours after plating cells, a scratch was gently performed in each of the wells with a sterile 200 μl micropipette tip, followed by two washes with medium to remove floating cells. Afterwards, cells were treated with LPS and immediately photographed in a Zeiss Axiovert 35 microscope (0 h time point). Cells were incubated for a further 48 or 72 h to allow time for migration into the cell-free area, fixed with paraformaldehyde and stained with DAPI. Photos were taken of the same region of the scratch. Quantification of cell migration was done using ImageJ, by counting the total number of cells in the field and the number of cells present in the slit.
Statistical analysis
Results are expressed as means ± S.E.M., and the data were analyzed by two-way analysis of variance with Bonferroni post tests using GraphPad Prism 5.01 software. A p value of b0.05 was considered significant. The number of experiments is indicated in the figure legends. 
Results
Absence of PrP C does not affect microglia morphology, adhesion or content of a microglial marker
We first examined the general morphology and the adhesion of microglia in primary cultures obtained from either wild type (WT) or Prnp-null (KO) mice. No difference was found between cells of distinct genotypes (Fig. 1 ). Next, we tested for the expression of Iba-1, a specific macrophage/microglia marker (Kanazawa et al., 2002) . Iba-1 staining was observed in over 97% of cells of both wild type and Prnp-null genotypes, and the pattern of expression and the amount of staining were similar in cells either expressing or not the prion protein (Fig. 2). 3.2. Translocation of NF-κB and production of cytokines in response to LPS are not affected by the lack of PrP C We next asked whether the lack of the prion protein would affect cell activation and cytokine production in response to bacterial lipopolysaccharide, a well-known microglial activator. NF-κB is an important upstream modulator of cytokine expression in microglia (Pahl, 1999) , and its translocation to the nucleus in response to infection is a marker of cellular activation (O'Neill and Kaltschmidt, 1997). As expected, LPS induced massive translocation to the nucleus of NF-κB (Fig. 3) . However, no differences in either NF-κB content or localization were observed when comparing wild type and Prnp-null microglia.
Accordingly, LPS induced a substantial inflammatory response, with the production by stimulated microglia of TNF-α, IL-1β and IL-6 (Fig. 4a-c) . Yet, the levels of inflammatory markers were similar in both wild type and Prnp-null microglia.
We next examined the production of regulatory cytokines, which help to control the inflammatory process and avoid its exacerbation and consequent tissue damage. LPS treatment induced the production of IL-10 again independent of PrP C (Fig. 4d) , whereas IL-4 levels were below the detection limit in the supernatants of microglia cultures of both genotypes (data not shown).
3.3. Upregulation of iNOS in response to LPS is not affected by the lack of PrP C Inflammatory mediators other than cytokines have multiple effects upon the inflammatory process, such as nitric oxide. The inducible nitric oxide synthase is a key enzyme in the production of NO following inflammatory stimulation, and thus it has an important role in the regulation of the immune responses, as its product affects virtually every step of the progression of inflammation (Guzik et al., 2003) .
We therefore tested whether the regulation of iNOS content in response to inflammation was dependent on the genotype of the microglia. To this end, we stimulated the cells with LPS and quantified the number of cells expressing the inducible NO synthase (Borghan et al., 2007) . Treatment with LPS induced increased number of iNOS expressing cells and fluorescence intensity, but the quantity of iNOS- positive cells and the intensity of the staining did not differ between cells from both genotypes (Fig. 5) .
Neither phagocytosis nor migratory capacity are affected by the lack of PrP C
The relevance of the prion protein for microglial physiology was also addressed in functional assays. We had previously found evidence of hyperphagocytosis by peritoneal macrophages and bystander retinal glial cells in Prnp-null mice as compared with wild type (de Almeida et al., 2005) . Phagocytic activity of microglia was therefore addressed in an assay of uptake of zymosan-FITC bioparticles. Surprisingly, although the basal phagocytic activity of microglial cells was high -as expected for young primary microglial cultures (Caldeira et al., 2014) -there was no sign of an effect of the microglia genotype in the uptake of zymosan before or after LPS treatment (Fig. 6) . Migratory capacity of microglial cells was investigated in a scratch assay. LPS treatment significantly increased migratory capacity of cells toward the scratch, but again no difference was found between genotypes (Fig. 7) .
Discussion
In the present study we found that primary Prnp-null microglia behave similarly to wild type cells in a variety of functional properties both in basal conditions, as well as in response to LPS. There were no differences between genotypes in (i) morphology; (ii) expression of the microglial marker Iba-1; (iii) translocation of NF-κB to the nucleus; (iv) production of several cytokines; (v) levels of inducible NO synthase; (vi) migration nor (vii) phagocytosis following activation.
Our results differ greatly from recent reports that PrP C contributes significantly to both the activation and inflammatory response of the BV-2 microglial cell line. In those studies, downregulation of Prnp with siRNA prior to M. bovis infection reduced bacteria-induced upregulation of IL-1β, TNF-α and iNOS, but not of IL-10 and TGF-β, consistent with a role for PrP C in the response of BV-2 cells to infection . Silencing of Prnp also affected the responsiveness of BV-2 cells to interferon-γ or IL-4, but not to IL-10, thus suggesting a role of PrP C in the modulation of microglia phenotype from quiescence to an activated state . The remarkable differences in the behavior of brain-derived microglia as compared to the BV-2 cell line are in line with similar comparisons between primary cells and corresponding cell lines from various tissues (Wilkening et al., 2003; LePage et al., 2005; Alge et al., 2006; Myers et al., 2008; Chamberlain et al., 2009; Cree et al., 2010; Kraus et al., 2010) . From our results, it is likely that major functional properties of brain microglia are relatively insensitive to the lack of the prion protein. However, a number of additional characteristics remain to be tested, such as, for example, the kinetics of nucleo-cytoplasmic shuttling of NF-κB.
Particular among the properties we now examined in primary microglia was the rate of phagocytosis. Our original findings (de Almeida et al., 2005) of hyperphagocytosis in peritoneal macrophages of Prnp-null mice of a mixed C57BL/6J-129/Sv genetic background (B6.129Sv), as compared with corresponding wild type, was confirmed in a recent study by other authors (Nuvolone et al., 2013) . Nonetheless, the extensive genetic analysis made by the Aguzzi group showed that the effect we had attributed to PrP C (de Almeida et al., 2005) was actually traceable to the signal regulatory protein α (Sirpa) gene, that significantly impacts phagocytosis by peritoneal macrophages (Matozaki et al., 2009) . A polymorphism of Sirpa is present in the 129S7/SvEvBrd genotype of the original embryonic stem cells that originated the B6.129Sv mice (Büeler et al., 1992) , and the Sirpa gene is closely linked to Prnp. Indeed, Sirpa was shown to co-segregate with the targeted Prnp locus for up to 17 generations in several 129Sv-derived hybrid mouse lines (Nuvolone et al., 2013) . The 129/Ola mouse sub-strain carries the same polymorphism of Sirpa as found in 129/Sv, and 129/Ola co-isogenic mice did not show differing phagocytosis between Prnp-null and wild type cells (Nuvolone et al., 2013) . In our original study (de Almeida et al., 2005) , we had reported hyperphagocytosis of peritoneal macrophages from the B10.129Ola strain used in the current study, as compared with wild type C57BL/10SnJ, but wild type B10.129Ola macrophages were not examined. The CD47-Sirpa signaling system, however, also regulates properties of polymorphonuclear cells, such as adhesion, migration and phagocytosis, as well as macrophage-mediated clearance of apoptotic neutrophils, with robust functional consequences (Parkos et al., 1996; Liu et al., 2001; Lawrence et al., 2009; Myers et al., 2011; Zen et al., 2013; Stenberg et al., 2013 Stenberg et al., , 2014 Greenlee-Wacker et al., 2014) . Interestingly, we have found no difference between Prnp-null and wild type neutrophils taken from B10.129Ola mice in their sensitivity to spontaneous or peroxideinduced apoptosis in vitro (Mariante et al., 2012) , nor in their recruitment to the peritoneal cavity following in vivo injections of zymosan (R.M. Mariante et al., unpublished results).
Taken together, the results with both neutrophils and microglia suggest that the mixed B10.129Ola sub-strain in our colony may have lost the differential effect of the Sirpa polymorphism derived from the 129Ola background (Nuvolone et al., 2013) . This could be due to segregation by chance of Sirpa after long-term backcrossing of B10.129Ola heterozygous mice into the C57BL/10SnJ strain. Alternatively, the latter strain may carry other genetic determinants that affect Sirpa-regulated functions, either alone or through epistasis, whereas such determinants are either absent or irrelevant for immune responses in the B6.129Sv mixed strain. The C57BL/6J and C57BL/10SnJ mice have been separately inbred since 1947 (JAX notes -http://jaxmice.jax.org/strain/000665. html), and expression of certain genes, single nucleotide polymorphisms, as well as functional properties of a variety of organs and systems have, indeed, been shown to differ between mice of either strain (Steward et al., 1999; Shuttleworth and Connor, 2001; Turk et al., 2004; Deacon et al., 2007; Xia et al., 2010; Wiltshire et al., 2011; Roche et al., 2012; Damerla et al., 2014) . Undoubtedly, the interplay of both Prnp and Sirpa genes and their products deserves further attention, to unravel both their genetic and functional interactions, which may affect not only immune cells but functional properties attributed to PrP C in other organs and systems. However, such an investigation is beyond the scope of the current study.
Conclusions
An extensive examination of various functional properties indicated that the lack of the prion protein has little effect upon the behavior of microglia, contrary to the distinctive properties of the BV-2 microglial cell line in the presence or the absence of PrP C . Given the growing interest in unraveling the functions of the prion protein in both health and disease, our data warrant a cautionary approach to the testing of 
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